July 30th, 2008
Read More…
Read More…
New drug - VolibrisHealthcare Republic (press release), UK - Jul 29, 2008GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Class II and III) to improve exercise capacity. …
|
Read More…
Read More…
Read More…
Posted in primary pulmonary hypertension | No Comments »
July 28th, 2008
Read More…
Read More…
Kentucky Children's Heart Center OpensUK News, KY - 6 hours ago… invasive electrophysiological study and ablation of abnormal electrical pathways; pulmonary hypertension; preventive cardiology; and cardiomyopathy. …
|
Read More…
Read More…
Viagra - New UsesHULIQ (press release), NC - 3 hours agoThe 2nd new use for Viagra is to treat babies who are born with pulmonary hypertension. Because Viagra allows more blood to flow to lung vessels, …
|
Read More…
Posted in primary pulmonary hypertension | No Comments »
July 28th, 2008
SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ — NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of Read More
- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting’s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ — Sanofi-aventis U.S. announced today that key study results from the company’s Read More
- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More
Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More
Survival analysis (6-year median follow-up) of the MOSAIC study presented at this year’s ASCO CHICAGO, June 3 /PRNewswire-FirstCall/ — FOLFOX4, an Eloxatin(R) (oxaliplatin injection)-based chemotherapy regimen, significantly improved the overall Read More
Posted in primary pulmonary hypertension | No Comments »
July 26th, 2008
- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting’s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ — Sanofi-aventis U.S. announced today that key study results from the company’s Read More
- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More
Posted in primary pulmonary hypertension | No Comments »
July 22nd, 2008
Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More
IRVINE, Calif., Feb. 20 /PRNewswire/ — LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare & Medicaid Services (CMS) of its disease Read More
Posted in primary pulmonary hypertension | No Comments »
July 21st, 2008
Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) ™ for physicians; Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians; Nurses - 0.25 nursing contact hours (0.25 contact hours are in the area of pharmacology) To Read More
Does Ezetimibe ENHANCE the Benefits of Statins? Old Diseases Make News An Erythropoietin-Stimulating Agent for Cancer-Related Anemia - No Benefit A New Approach to Osteoporosis and Fracture Risk Survival Rate From In-Hospital Cardiac Read More
- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More
Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More
Posted in primary pulmonary hypertension | No Comments »
|
|